Image not available in RecallScope.
Arrow-trerotola products
Official notice
18 Jan 2022
An official Health Canada notice concerns Arrow-trerotola products. Teleflex is initiating a voluntary field safety corrective action due to reports received indicating PTD tip separation during use. If the tip separates during use, clinicians may exercise their medical judgment to either retrieve endovascularly with a snare device or with a minor surgical procedure, or elect not to retrieve the tip given the recognition that embolism of a small and inert tip may be less likely to be harmful than extraordinary attempts to retrieve said tip. Partial or full embolization of foreign material into the arterial or venous circulation is possible, potentially leading to vascular complications, including but not limited to mechanical obstruction of an artery or vein, arterial or venous thrombosis, ischemia, or infarction in the territory subtended by an obstructed or thrombosed artery (including pulmonary embolism and infarction), and remotely, endovascular infection. The consequences of embolizing foreign material into the peripheral or pulmonary circulation or components thereof are substantially determined by the size of the embolus. Clinicians may also elect to exclude the embolus from the circulation by trapping the embolus outside a newly deployed stent. Recall start date: Jan 12, 2022 Published 2022-01-18.
What to do now
Contact the manufacturer if you require additional information.
Recall number
63834
Official notice
2022-01-18
The hazard
The hazard
Teleflex is initiating a voluntary field safety corrective action due to reports received indicating PTD tip separation during use. If the tip separates during use, clinicians may exercise their medical judgment to either retrieve endovascularly with a snare device or with a minor surgical procedure, or elect not to retrieve the tip given the recognition that embolism of a small and inert tip may be less likely to be harmful than extraordinary attempts to retrieve said tip. Partial or full embolization of foreign material into the arterial or venous circulation is possible, potentially leading to vascular complications, including but not limited to mechanical obstruction of an artery or vein, arterial or venous thrombosis, ischemia, or infarction in the territory subtended by an obstructed or thrombosed artery (including pulmonary embolism and infarction), and remotely, endovascular infection. The consequences of embolizing foreign material into the peripheral or pulmonary circulation or components thereof are substantially determined by the size of the embolus. Clinicians may also elect to exclude the embolus from the circulation by trapping the embolus outside a newly deployed stent. Recall start date: Jan 12, 2022
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Product 2
Product 3
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Arrow Subsidiary Of Teleflex, Arrow-trerotola.
Source & status
Source & status
Recall details
Recall details
Recall number
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.